Dana-Farber Cancer Institute
Dana-Farber Cancer Institute, founded in 1947 by Sidney Farber, MD, is a leading cancer research and treatment center affiliated with Harvard Medical School and part of the Dana-Farber/Harvard Cancer Center.
History
Dana-Farber Cancer Institute was founded in 1947 by Sidney Farber, MD, initially as the Children's Cancer Research Foundation. In 1983, the institution was renamed Dana-Farber Cancer Institute in honor of its founder and acknowledging the significant support from the Charles A. Dana Foundation. Over the decades, it has grown and evolved to become a leading cancer research and treatment center.
Collaboration and Affiliations
Dana-Farber Cancer Institute collaborates closely with Brigham and Women's Hospital and Boston Children's Hospital. It is also a principal teaching affiliate of Harvard Medical School. Additionally, it is part of the Dana-Farber/Harvard Cancer Center, a federally designated comprehensive cancer center. These partnerships enable the institute to integrate cutting-edge research with clinical excellence.
Clinical Services and Patient Care
Dana-Farber Cancer Institute provides comprehensive adult and pediatric cancer care. Annually, they handle over 640,000 outpatient visits and more than 1,000 hospital discharges. The institute offers a range of specialized treatment centers and clinical services, including the Centers for Early Detection and Interception. These centers focus on identifying cancer at its earliest stages and intervening promptly to improve patient outcomes.
Clinical Trials
Dana-Farber Cancer Institute conducts extensive research, with over 1,100 open clinical trials targeting various cancer types and conditions. These trials are crucial for developing new treatments and improving existing therapies. The ongoing research efforts contribute significantly to advancing the understanding and management of cancer.
Center for Global Health Equity
In 2023, Dana-Farber Cancer Institute established the Center for Global Health Equity. This initiative aims to address and reduce global inequities in cancer care. The Center for Global Health Equity extends Dana-Farber's impact beyond local boundaries, focusing on global health initiatives to improve cancer care internationally.
The Jimmy Fund
The Jimmy Fund is Dana-Farber Cancer Institute's principal charity, dedicated to supporting cancer research and patient care. It plays a vital role in funding critical research projects and providing essential resources for patient support. The Jimmy Fund has been instrumental in advancing the institute's mission and expanding its reach.